🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to evaluate the efficacy and safety of upada...
Status
Completed
Location
East View Medical Research, LLC /ID# 171133
Start Date
2017-11-29
Trial ID
NCT03345836
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy, pharmacokine...
Status
Recruiting
Location
UCSF Ron Conway Gateway Medical Building
Start Date
2026-01-22
Trial ID
NCT07159841
Treatments Being Tested
The primary objective of Part 1 of this study is to evaluate the effects of...
Status
Terminated
Location
Research Site
Start Date
2017-11-15
Trial ID
NCT03222973
Treatments Being Tested
This multi-center, randomized, double-blind, placebo-controlled parallel-gr...
Status
Completed
Location
Banner Alzheimer's Institute
Start Date
2010-11-30
Trial ID
NCT01224106
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of eslicarba...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2004-07
Trial ID
NCT00957047
Treatments Being Tested
This Phase 1 study is intended to explore the safety, tolerability, pharmac...
Status
Completed
Location
Centre for Human Drug Research
Start Date
2019-03-11
Trial ID
NCT03846648
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of switchin...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-10
Trial ID
NCT02417064
This Phase 3 study is conducted to evaluate lanifibranor in adults with NAS...
Status
Active Not Recruiting
Location
Objective Health - Birmingham Gastroenterology Associates
Start Date
2021-08-19
Trial ID
NCT04849728
Primary Objectives: Part A (dose ranging study): To demonstrate that sari...
Status
Completed
Location
Investigational Site Number 840070
Start Date
2010-03
Trial ID
NCT01061736
Treatments Being Tested
This trial is extension part of the P04280 (placebo-controlled, double-blin...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00732875
Treatments Being Tested